Search results
Novavax's updated COVID vaccine is here. What to know about the shot.
Yahoo Life Style via AOL· 7 months agoUnlike Moderna and Pfizer's mRNA vaccines, the Novavax vaccine utilizes a protein-based approach....
Novavax's (NVAX) Updated COVID Jab Gets WHO Nod for Emergency Use
Zacks via Yahoo Finance· 5 months agoNovavax NVAX announced that the World Health Organization (“WHO”) has granted emergency use listing...
Novavax Stock May Soar 379%, According to Wall Street. Is the Stock a Buy Right Now?
Motley Fool via Yahoo Finance· 3 months agoNovavax (NASDAQ: NVAX) soared more than 2,700% early in the pandemic as investors bet on its ability...
Novavax (NVAX) Down as EU Adds Side Effects to COVID Jab Label
Zacks via Yahoo Finance· 2 years agoThe administration of Novavax's (NVAX) COVID-19 vaccine leads to some cases of severe allergic...
FDA signs off on updated protein-based Covid-19 vaccine from Novavax
CNN via AOL· 7 months agoThe US Food and Drug Administration on Tuesday authorized Novavax’s updated protein-based Covid-19...
IBD/TIPP Poll: There's Bad News For Novavax's Covid Vaccine
Investor's Business Daily· 2 years agoNovavax could struggle to find a U.S. market for its Covid vaccine, according to the latest IBD/TIPP...
Has Novavax Just Solved Its Biggest Problem?
Motley Fool via Yahoo Finance· 2 months agoMany investors have seen Novavax (NASDAQ: NVAX) as a promising recovery story ever since the biotech launched a plan to cut costs to better match the...
Novavax's COVID-19 vaccine rollout off to sluggish start with just 7,000 doses in arms
ABC News via Yahoo News· 2 years agoFollowing its emergency authorization last month, just 7,300 doses of Novavax's COVID-19 vaccine...
1 of the Biggest Risks Facing Novavax Has Now Been Resolved: Is Now the Time to Buy the Stock?
Motley Fool via Yahoo Finance· 2 months agoSince 2021, shares of Novavax (NASDAQ: NVAX) have absolutely crumbled, falling by a whopping 95%....
Does This Message From Moderna Mean Bad News for Novavax?
Motley Fool· 7 months agoModerna (NASDAQ: MRNA) recently gave an update on its pipeline and future goals, and the biotech had...